EC includes anti-JC virus antibody status as PML risk factor

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

EC includes anti-JC virus antibody status as PML risk factor

Postby MSUK » Wed Jun 22, 2011 12:09 am

EC includes anti-JC virus antibody status as PML risk factor in Tysabri labeling

Image

Biogen Idec Inc. and Elan Corporation, plc Wednesday said the European Commission has approved the inclusion of anti-JC virus antibody status as an additional factor to aid in stratifying patients at risk for developing progressive multifocal leukoencephalopathy in the Summary of Product Characteristics for Tysabri in the European Union.

In addition, as part of a standard review process, the European Commission concluded the quality, safety and efficacy of Tysabri continue to be adequately demonstrated and renewed the EU five-year Marketing Authorisation.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1905
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service